DEA's Proposed Rules on Controlled Substances Prescribing via Telemedicine and Their Uncertain Impact on the Pharmacy Community

Proposed rules would permit a telehealth provider to prescribe only up to a 30-day supply of a Schedule III-V non-narcotic controlled substance or buprenorphine through telehealth without the patient first being evaluated in person by a provider.

Related Keywords

White House ,District Of Columbia ,United States ,American , ,Walmart Inc ,American Telemedicine Association ,National Association Of Boards Pharmacy ,Us Drug Enforcement Administration ,Health Corp ,Enforcement Administration ,Tada Images ,Haight Act ,Prescribing Under ,Clarity Regarding Pharmacist ,National Association ,